FSD Pharma Submits a Phase-1b Clinical Trial Application for

TORONTO, ON / ACCESSWIRE / March 11, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and

Related Keywords

Toronto , Ontario , Canada , Australia , United States , , Pharma Inc , Nasdaq , Company Clinical Trial Application , Clinical Trial Application , Healthy Volunteers , Induced State , Alcohol Intoxication ,